Drug shortages in Israel, revisited: a bitter pill to swallow
Abstract Background In 2017, we published an article addressing drug shortages (DS) in Israel, exploring regulatory perspectives, challenges, and potential solutions. Since then, DS remain a significant concern for patients, healthcare providers, and policymakers globally. In this updated article, w...
Main Authors: | Eyal Schwartzberg, Eli Marom, Alla Vishkautzan, Einat Gorelik, Segev Shani |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-03-01
|
Series: | Israel Journal of Health Policy Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13584-024-00600-4 |
Similar Items
-
Prospective Risk Assessment of Medicine Shortages in Europe and Israel: Findings and Implications
by: Nenad Miljković, et al.
Published: (2020-03-01) -
Drug Shortage: Causes, Impact, and Mitigation Strategies
by: Sundus Shukar, et al.
Published: (2021-07-01) -
Practical Implications From European Hospital Pharmacists on Prospective Risk Assessment for Medicine Shortages
by: Nenad Miljković, et al.
Published: (2020-08-01) -
The physician shortage in Israel and a policy proposal for improvement
by: Yulia Treister-Goltzman, et al.
Published: (2023-02-01) -
Depression in doctors: A bitter pill to swallow
by: K. Outhoff
Published: (2019-03-01)